Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease
Reprogramming of human somatic cells uses readily accessible tissue, such as skin or blood, to generate embryonic-like induced pluripotent stem cells (iPSCs). This procedure has been applied to somatic cells from patients who are classified into a disease group, thus creating “disease-specific” iPSC...
Main Authors: | Saha, Krishanu, Jaenisch, Rudolf |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2015
|
Online Access: | http://hdl.handle.net/1721.1/96182 |
Similar Items
-
CNS disease models with human pluripotent stem cells in the CRISPR age
by: Muffat, Julien, et al.
Published: (2018) -
Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues
by: Hanna, Jacob, et al.
Published: (2015) -
Induced Pluripotent Stem Cells Meet Genome Editing
by: Hockemeyer, Dirk, et al.
Published: (2018) -
Reprogramming of Human Peripheral Blood Cells to Induced Pluripotent Stem Cells
by: Staerk, Judith, et al.
Published: (2015) -
Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions
by: Saha, Krishanu, et al.
Published: (2012)